Repurposing Off-Patent Medicines: Insights from...

By HEOR Staff Writer

December 8, 2025

EU Pilot Initiative for Repurposing Off-Patent Medicines: Core Outcomes and Regulatory Support Repurposing off-patent medicines offers a p...
Innovations in Haematology Cell Therapy at ASH 2025
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft ...
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Strengthening EU Pharmaceutical Supply Security Through the Critical Medicine...
Biomanufacturing Excellence Act: Strengthening U.S. Biopharmaceutical Manufac...
Medicare Drug Price Negotiations: Major Savings for Seniors on Cancer and Chr...
Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Res...
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management
GLP-1RAs Psychiatric Care: Transforming Metabolic Management for Psychotropic...
NICE Endorses Obecabtagene Autoleucel Therapy for Adult Relapsed B-Cell Leuka...
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Rethinking HEOR Market Access Integration: A Call for Early Engagement Before...